Stack Stack · multiple compounds
Cagrilintide + Retatrutide
Research stack pairing a long-acting amylin analog with a GIP/GLP-1/glucagon triple agonist.
What's in it
2 ingredients in separate vials. Tap one to open its own page.
- 01
Cagrilintide
Long-acting amylin analog
Acylated amylin analog used in laboratory research on amylin/calcitonin receptor signaling.
How it works: Cagrilintide is a long-acting analogue of amylin, a pancreatic hormone that induces satiety.
Open Cagrilintide → - 02
Retatrutide
GIP / GLP-1 / glucagon triple agonist
Investigational triple-hormone receptor agonist evaluated in phase 2/3 obesity trials.
How it works: Retatrutide (LY3437943) is a single peptide agonist of three receptors: GIP, GLP-1 and glucagon.
Open Retatrutide →
No schedule on file
This is a reference-only entry. The site lists its vial sizes and concentrations only — there is no published schedule for it here.
Laboratory reference · in vitro research data
- Research vial sizes
- 10 mg
- Dosing data
- Not listed — reference entry covers vial concentration only.
- Storage
- Powder: 2–8 °C, or −20 °C for longer storage. After mixing with BAC water: 2–8 °C, use within about 4 weeks.
Reconstitution concentrations
Concentration per BAC-water volume; 10 units = 0.1 mL on a U-100 syringe.
| Vial | BAC water | mg/mL | mg per 10 u |
|---|---|---|---|
| 10 mg | 1 mL | 10 | 1 |
| 10 mg | 2 mL | 5 | 0.5 |
| 10 mg | 3 mL | 3.33 | 0.333 |